Novogen to Establish China Entity to Further Commercialization and Partnerships in World's Second-Largest Pharmaceutical Market
Novogen Ltd, an Australian oncology drug development company, announces today that it has entered into a Letter of Intent with Cedrus Investments Ltd for advisory services in order to establish a corporate structure focused on expansion into the Greater China region.
View full press release